Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer

Published:1989-05 Issue:5 Volume:47 Page:669-677
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Faber L.Penfield,Kittle C.Frederick,Warren William H.,Bonomi Philip D.,Taylor Samuel G.,Reddy Salitha,Lee Myung-Sook

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference21 articles.

1. Phase I–II study of 120-hour infused 5-FU and split course radiation therapy in localized non-small cell lung cancer;Byfield;Cancer Treat Rep,1983

2. Clinical trial of cisplatin and 5-FU infusion as initial treatment of advanced squamous cell carcinoma of the head and neck;Kish;Cancer Treat Rep,1982

3. Cisdichlorodiammineplatinum, II. Combination of chemotherapy and cross-resistance studies with tumors of mice;Schabel;Cancer Treat Rep,1979

4. Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin;Overgaard;Cancer Treat Rep,1981

5. Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy;Taylor;Cancer Treat Rep,1985

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges;Frontiers in Oncology;2023-12-08

2. The efficacy of neoadjuvant EGFR-TKI therapy combined with radical surgery for stage IIIB lung adenocarcinoma harboring EGFR mutations: A retrospective analysis based on single center;Frontiers in Oncology;2023-01-26

3. Early Prediction of Radiotherapeutic Efficacy in a Mouse Model of Non-Small Cell Lung Carcinoma Using <sup>18</sup>F-FLT and <sup>18</sup>F-FDG PET/CT;The Journal of Medical Investigation;2023

4. Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database;Medicina;2021-11-04

5. Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients;Medical Council;2019-12-09